HS 6203-43-00-20 – Shorts

Tariff data as of T2026-2, effective Sept 1, 2026, last verified Oct 21, 2026

Men's or boys' suits, ensembles, jackets, blazers, trousers, bib and brace overalls, breeches and shorts (other than swimwear). › Of synthetic fibres › Shorts

MFN duty rate

18 %

GST

5%

Unit of measure

NMB

Shorts

Estimate duty & taxes · Get classification help

Preferential tariff rates

• CETA: Free
• Peru: Free
• Panama (PAT): Free
• Honduras (HNT): Free
• LDCT: Free
• CPTPP: Free
• New Zealand: 11%
• Iceland: Free
• MXT/CUSMA (Mexico): Free
• UK: Free
• CPTPP – United Kingdom (CPUKT): Free
• Australia: 11%
• Ukraine: Free
• Switzerland–Liechtenstein (SLT): Free
• Jordan (JT): Free
• Colombia: Free
• UST/CUSMA (US): Free
• Korea: Free
• Norway (NT): Free
• Commonwealth Caribbean Countries Tariff (CCCT): Free
• Chile: Free
• Israel (CIAT): Free
• Costa Rica (CRT): Free

Preference requires qualifying origin and origin proof or certification.

Frequently asked questions

What is the MFN duty on Shorts (HS 6203-43-00-20)?

The T2026-2 MFN rate for tariff item 6203.43.00 is 18%. Specific or compound rates require manual calculation. Classification and origin must be verified with CBSA.

What is the duty on HS 6203-43-00-20 from the US?

Qualifying US-origin goods with origin proof use UST/CUSMA at Free. This item is not on any US surtax schedule in force in TariffPlus surtax data (checked against CBSA). GST/HST and any applicable personal-import provincial tax are additional.

Which trade agreement rates apply to HS 6203-43-00-20?

CETA: Free; Peru: Free; Panama (PAT): Free; Honduras (HNT): Free; LDCT: Free; CPTPP: Free; New Zealand: 11%; Iceland: Free; MXT/CUSMA (Mexico): Free; UK: Free; CPTPP – United Kingdom (CPUKT): Free; Australia: 11%; Ukraine: Free; Switzerland–Liechtenstein (SLT): Free; Jordan (JT): Free; Colombia: Free; UST/CUSMA (US): Free; Korea: Free; Norway (NT): Free; Commonwealth Caribbean Countries Tariff (CCCT): Free; Chile: Free; Israel (CIAT): Free; Costa Rica (CRT): Free. Preferential treatment requires qualifying origin and certification. Rates are informational; CBSA is authoritative.